- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -1.33 | -0.68 | 96.70 |
| EPS, GAAP | -1.33 | -0.68 | -0.68 |
| Consensus Estimate | -1.43 | -0.62 | 132.43 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -3.94 | -2.17 | 82.06 |
| EPS, GAAP | -3.94 | -2.17 | 82.06 |
| Consensus Estimate | -3.21 | -2.30 | 39.48 |
| HTWR | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 1.15 |
| Price/Sales | 12.13 | 1.95 |
| Beta | 0.56 | 0.94 |
| 5/23/2012 | Can US Biotechs Inject Life To Australia's IPO Market? (WSJ.com) |
| 4/26/2012 | Stocks to Watch: H&R Block, Aetna, Exxon Mobil (WSJ.com) |
| 4/26/2012 | Top Active Trader Alerts (AKAM, CRUS, CTXS, CROX, EA, EQIX, HTWR, HRB, LOGI, NUAN, SKX, STMP, TQNT, XLNX) (24/7 Wall St) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)